Preclinical development of a humanized chimeric antigen receptor against B-cell maturation antigen for multiple myeloma

Multiple myeloma is a prevalent and incurable disease, despite the development of new and effective drugs. The recent development of chimeric antigen receptor (CAR)T cells has shown impressive results in the treatment of patients with relapsed or refractory hematologic B-cell malignancies. In recent...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Main Authors: Perez-Amill, Lorena, Suñe, Guillermo, Antoñana-Vildosola, Asier, Castella, Maria, Najjar, Amer, Bonet, Jaume, Fernández-Fuentes, Narcis, Inogés, Susana, López, Ascensión, Bueno, Clara, Juan, Manel, Urbano-Ispizua, Alvaro, Martín-Antonio, Beatriz
Formato: Artigo
Idioma:Inglês
Publicado: Fondazione Ferrata Storti 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776337/
https://ncbi.nlm.nih.gov/pubmed/31919085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.228577
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares